Related Experiment Video
Updated: May 10, 2026

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
Study on the treatment of acute thallium poisoning
Hong-Tao Zhang1, Bao-Ping Qiao, Bao-Ping Liu
1Blood Purification Center (H-TZ, X-GZ) and Department of Urology (B-PQ), The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Institute of Nephrology (H-TZ), Zhengzhou University, Zhengzhou, China; Key Discipline Laboratory of Clinical Medicine (H-TZ, B-PQ), Jiaozuo, China; and Department of Nuclear Medicine (B-PL), The Second Charity Hospital of Henan Province, Jiaozuo, China.
Background:
Acute thallium poisoning rarely occurs but is a serious and even fatal medical condition. Currently, patients with acute thallium poisoning are usually treated with Prussian blue and blood purification therapy. However, there are few studies about these treatments for acute thallium poisoning.
Methods:
Nine patients with acute thallium poisoning from 1 family were treated successfully with Prussian blue and different types of blood purification therapies and analyzed.
Results:
Prussian blue combined with sequential hemodialysis, hemoperfusion and/or continuous veno-venous hemofiltration were effective for the treatment of patients with acute thallium poisoning, even after delayed diagnosis.
Conclusions:
Blood purification therapies help in the clearance of thallium in those with acute thallium poisoning. Prussian blue treatment may do the benefit during this process.
Related Concept Videos
Pharmaceutical Poisoning: Treatment Strategies
Prevention of Further Absorption of Poison
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies

